Skip to content
10-Q

Quarterly Report

XBIOTECH INC. XBIT

0001171843-24-002746

← back to feed
Filed
May 10, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 10, 2024 30.46M sh
Cash And Equivalents Q1 2024 · Mar 31, 2024 $201.04M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $200.02M
Current Liabilities Q1 2024 · Mar 31, 2024 $16.88M
Current Liabilities Q1 2024 · Dec 31, 2023 $6.1M
Total Liabilities Q1 2024 · Mar 31, 2024 $18.58M
Total Liabilities Q1 2024 · Dec 31, 2023 $7.77M
Current Assets Q1 2024 · Mar 31, 2024 $203.06M
Current Assets Q1 2024 · Dec 31, 2023 $201.72M
Total Assets Q1 2024 · Mar 31, 2024 $227.86M
Total Assets Q1 2024 · Dec 31, 2023 $226.62M
Capex Q1 2024 · Mar 31, 2023 $6K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$4.81M
Stockholders Equity Q1 2024 · Mar 31, 2023 $236.91M
Stockholders Equity Q1 2024 · Dec 31, 2022 $240.4M
Eps Basic Q1 2024 · Mar 31, 2023 −$0.13
Sga Expense Q1 2024 · Mar 31, 2023 $915K
Rd Expense Q1 2024 · Mar 31, 2023 $6.23M
Net Income Q1 2024 · Mar 31, 2023 −$3.82M
Operating Income Q1 2024 · Mar 31, 2023 −$7.15M